Clinical Trial Update: Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing short-course radiotherapy with CapeOx and a PD-1 inhibitor after local excision for high-risk early rectal cancer; study curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• PD-1 inhibitor

Snippet

Sponsor: Fudan University | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING